ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,253, issued on Dec. 9, was assigned to Xencor Inc. (Pasadena, Calif.).
"Anti-human C5 antibodies" was invented by Aaron Keith Chamberlain (Pasadena, Calif.), Bassil Dahiyat (Altadena, Calif.), John R. Desjarlais (Pasadena, Calif.), Sher Bahadur Karki (Santa Monica, Calif.) and Gregory Alan Lazar (Indianapolis).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein anti-human claudin 6 (CLDN6) and anti-human C5 antibodies."
The patent was filed on May 23, 2025, under Application No. 19/218,154.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%...